Wegovy vs Orlistat: UK Pharmacy Comparison | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy vs Orlistat - UK Price From £69.00

Compare Wegovy and Orlistat at the cheapest UK price from £69 plus £20 off your first order with code WEIGHTLOSSNEW.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy vs Orlistat UK Pharmacy Comparison: Which Weight Loss Treatment Works Best?

Published on: June 03, 2026

Choosing between wegovy vs orlistat uk pharmacy options requires understanding how these two MHRA-licensed weight loss treatments differ in mechanism, efficacy, and suitability. As a UK-registered pharmacy with thousands of weight management consultations completed, we've guided patients through this exact decision daily, and this comprehensive comparison draws on clinical trial data and real-world experience to help you make an informed choice.

How Wegovy and Orlistat Work: Fundamentally Different Mechanisms

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone to regulate appetite, slow gastric emptying, and enhance feelings of fullness [1]. Administered as a once-weekly subcutaneous injection, it works centrally on brain appetite centres and peripherally on the digestive system to reduce calorie intake naturally.

Orlistat operates through an entirely different mechanism—it inhibits pancreatic and gastric lipases, enzymes responsible for breaking down dietary fats [2]. By blocking approximately 30% of dietary fat absorption, orlistat reduces calorie intake mechanically rather than hormonally. It's taken as a 120mg capsule three times daily with meals containing fat.

This fundamental difference means Wegovy addresses appetite and satiety signals, whilst orlistat focuses purely on nutrient absorption. Neither medication is a substitute for lifestyle modification—both require commitment to dietary changes and increased physical activity for optimal results, as confirmed by NICE guidance on weight management interventions.

Clinical Efficacy: Wegovy vs Orlistat Weight Loss Results

The STEP 1 trial demonstrated that adults using Wegovy achieved an average 14.9% total body weight reduction over 68 weeks, with 86.4% of participants losing at least 5% of their baseline weight [1]. In contrast, orlistat trials typically show average weight loss of 2.9kg more than placebo over 12 months, equating to approximately 3-5% additional body weight reduction [2].

Head-to-head comparisons aren't available, but when examining clinical trial data side by side, semaglutide-based treatments consistently produce two to three times greater weight reduction than orlistat. The STEP programme also recorded significant improvements in cardiometabolic markers including HbA1c, blood pressure, and lipid profiles [3].

However, efficacy must be balanced against individual circumstances. Orlistat may be more appropriate for patients who prefer oral medication, have contraindications to GLP-1 agonists, or require a lower-cost option. Our clinical team assesses medical history, BMI, comorbidities, and personal preferences during consultation to recommend the most suitable treatment.

Realistic Expectations for Weight Loss Outcomes

Clinical trials represent controlled conditions—real-world results vary based on adherence, dietary modifications, exercise habits, and metabolic factors. We've observed that patients who combine either medication with structured nutrition plans and regular physical activity achieve results closer to trial averages, whilst those relying solely on medication without lifestyle changes see diminished outcomes. Your UK prescriber will discuss realistic weight loss targets during your free consultation, typically aiming for 5-10% body weight reduction as an initial goal that delivers meaningful health benefits.

Side Effect Profiles: What to Expect from Each Treatment

Wegovy's most common adverse effects are gastrointestinal: nausea (44% of trial participants), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These symptoms typically emerge during dose escalation and diminish over 4-8 weeks as the body adjusts. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies, not confirmed in humans).

Orlistat's side effects relate directly to its fat-blocking mechanism—oily stools, faecal urgency, flatulence with discharge, and increased bowel movements affect up to 27% of users [2]. These effects worsen with high-fat meals and can be socially disruptive. However, orlistat carries no systemic absorption, meaning it doesn't interact with most medications or cause metabolic disturbances.

From a practical standpoint, Wegovy's side effects are typically manageable through dose titration and dietary adjustments (smaller meals, avoiding high-fat foods initially), whilst orlistat's effects require strict dietary fat restriction—generally below 30% of total calories. Patients who struggle with gastrointestinal symptoms on one medication may tolerate the other better, and our pharmacists provide detailed management strategies during dispensing.

Feature Wegovy (Semaglutide) Orlistat
Mechanism GLP-1 receptor agonist Lipase inhibitor
Administration Once-weekly injection Three times daily oral
Average Weight Loss 14.9% over 68 weeks 3-5% over 12 months
Starting Price From £69.00 Competitive UK pricing
Common Side Effects Nausea, diarrhoea, vomiting Oily stools, faecal urgency
Prescription Required Yes Yes (120mg strength)
BMI Requirement ≥30 or ≥27 with comorbidity ≥28 with risk factors or ≥30
Treatment Duration Long-term (68+ weeks studied) 12-week courses, renewable

Eligibility Criteria and Prescribing Guidelines in the UK

NICE guidelines recommend considering pharmacological weight management for adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or dyslipidaemia [4]. Wegovy is specifically licensed for adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity, who have demonstrated inability to achieve weight loss through diet and exercise alone.

Orlistat has broader eligibility—it can be prescribed for BMI ≥28 kg/m² with risk factors, or BMI ≥30 without comorbidities. It's also available over the counter as a 60mg formulation (Alli), though the prescription-strength 120mg version (Xenical) delivers superior efficacy. Orlistat may be preferred for patients with contraindications to GLP-1 agonists, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Both medications require ongoing monitoring. NICE recommends discontinuing treatment if patients fail to lose at least 5% of initial body weight after 12 weeks at therapeutic dose. During your online consultation, our UK prescribers assess your medical history, current medications, weight loss goals, and previous treatment attempts to determine which option aligns with clinical guidelines and your individual needs.

Contraindications and Special Populations

Wegovy is contraindicated in pregnancy, with medullary thyroid carcinoma history, and in patients with severe gastrointestinal disease. Orlistat should be avoided in chronic malabsorption syndrome, cholestasis, and during pregnancy. Both require caution in patients taking anticoagulants (orlistat can affect vitamin K absorption), antidiabetic medications (dose adjustments may be needed), or with history of pancreatitis. Our clinical assessment identifies these factors before prescribing, ensuring patient safety remains paramount.

Dosing, Administration, and Treatment Duration

Wegovy follows a structured dose-escalation schedule over 16-20 weeks, starting at 0.25mg weekly and increasing monthly to the maintenance dose of 2.4mg weekly [1]. This gradual titration minimises gastrointestinal side effects whilst allowing physiological adaptation. The pre-filled injection pens are administered subcutaneously in the abdomen, thigh, or upper arm—most patients find the process straightforward after initial guidance.

Orlistat is taken as one 120mg capsule with each main meal containing fat, up to three times daily. If a meal is missed or contains no fat, the dose should be omitted. Patients must take a daily multivitamin supplement (at bedtime, separate from orlistat) because the medication reduces absorption of fat-soluble vitamins A, D, E, and K [2].

Treatment duration varies by individual response. Clinical trials evaluated Wegovy for up to 68 weeks, with many patients continuing beyond that timeframe under medical supervision. Orlistat is typically prescribed for 12-week initial courses, with continuation dependent on achieving ≥5% weight loss. Both treatments are most effective as part of long-term weight management programmes rather than short-term interventions—our pharmacists provide ongoing support and monitoring throughout your treatment journey.

Practical Considerations for Daily Life

Wegovy's once-weekly dosing offers convenience compared to orlistat's thrice-daily regimen, particularly for patients with busy schedules or those who struggle with medication adherence. However, the injection format may deter needle-averse individuals, whilst orlistat's oral capsules are more familiar. Storage requirements differ too—Wegovy pens must be refrigerated until first use (then can be stored at room temperature for 28 days), whereas orlistat capsules require standard room-temperature storage. Consider your lifestyle, travel habits, and personal preferences when discussing options with your prescriber.

Cost Comparison and Value for UK Patients

At Cured Pharmacy, Wegovy is available from £79.00 per pen, with transparent pricing displayed before your free consultation begins. This represents competitive UK pricing with no hidden fees—what you see is what you pay, including prescriber assessment and discreet home delivery.

When evaluating cost-effectiveness, consider the total treatment expense over time, including consultation fees, medication costs, and potential for dose adjustments. Wegovy's once-weekly dosing means one pen lasts one week, whilst orlistat requires 21 capsules weekly (three daily for seven days). Both medications represent an investment in health that should be weighed against potential medical costs of obesity-related complications—cardiovascular disease, type 2 diabetes, and joint problems.

Our pharmacy guarantees the lowest prices in the UK for genuine, MHRA-licensed medications. We've eliminated the markup typically added by high-street chains, passing savings directly to patients. Your total cost depends on treatment duration and prescriber-recommended dose, which our clinical team determines based on your individual response and weight loss progress. Many patients find that achieving clinically significant weight loss delivers value far beyond the monetary investment through improved health markers, reduced comorbidity risk, and enhanced quality of life.

Scientific References

  1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications including diet and exercise. Neither Wegovy nor orlistat is suitable for everyone—your prescriber will assess your medical history to determine the most appropriate treatment option.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Which is more effective for weight loss: Wegovy or orlistat?
Clinical trial data shows Wegovy produces significantly greater weight loss—an average 14.9% body weight reduction compared to orlistat's 3-5% additional loss beyond placebo. However, individual response varies, and the most effective treatment depends on your medical history, tolerance, and adherence to lifestyle modifications.
Can I take Wegovy and orlistat together?
There's no pharmacological contraindication to combining these medications, but it's rarely recommended as they work through different mechanisms and combining them doesn't necessarily enhance results. Your UK prescriber will assess whether combination therapy is appropriate for your specific circumstances during consultation.
How quickly will I see results with wegovy vs orlistat uk pharmacy treatments?
Wegovy users typically notice appetite reduction within 1-2 weeks, with measurable weight loss by week 4, whilst orlistat's effects appear within 24-48 hours as dietary fat passes unabsorbed. Clinically significant weight loss (≥5% body weight) usually occurs within 12 weeks for both treatments when combined with lifestyle modifications.
Do I need a prescription for Wegovy or orlistat in the UK?
Yes, both medications require a prescription from a UK-registered prescriber. At Cured Pharmacy, our clinical team provides a free online consultation (under 3 minutes) to assess your suitability, with same-day prescribing decisions for eligible patients.
What happens if I don't lose weight on orlistat—can I switch to Wegovy?
If you haven't achieved ≥5% weight loss after 12 weeks on orlistat at the full dose with appropriate dietary changes, switching to a GLP-1 agonist like Wegovy may be considered. Our prescribers review your treatment history and response to determine the most appropriate next step during reassessment.
Are there any foods I should avoid on wegovy vs orlistat uk pharmacy medications?
Orlistat requires limiting dietary fat to below 30% of total calories to minimise gastrointestinal side effects, whilst Wegovy doesn't require specific food restrictions, though smaller, lower-fat meals may reduce nausea during initial weeks. Both treatments work best alongside a balanced, calorie-controlled diet that our pharmacists can help you plan.
How long can I stay on Wegovy or orlistat safely?
Both medications have been studied for extended periods—Wegovy for 68+ weeks in clinical trials, orlistat for up to 4 years. Treatment duration depends on individual response, tolerability, and ongoing medical supervision. Our clinical team monitors your progress and adjusts treatment plans as needed to ensure safety and efficacy.
Will I regain weight after stopping Wegovy or orlistat?
Weight regain is common after discontinuing any weight loss medication if lifestyle habits revert to pre-treatment patterns. Maintaining weight loss requires ongoing commitment to dietary changes, physical activity, and behavioural modifications. Our pharmacists provide guidance on transitioning off medication whilst preserving your weight loss achievements through sustainable lifestyle strategies.
Is Wegovy or Orlistat cheaper at UK pharmacies?
Wegovy starts from £69 at Cured Pharmacy, while Orlistat typically costs £20-£40 per month. Although Orlistat has a lower upfront cost, Wegovy offers superior weight loss results and may provide better long-term value for many patients seeking significant weight reduction.
Can I switch from Orlistat to Wegovy through Cured Pharmacy?
Yes, you can switch from Orlistat to Wegovy at Cured Pharmacy after a consultation with our UK-registered prescribers. Many patients switch because Wegovy typically delivers greater weight loss results, and our clinical team will assess your suitability and create a safe transition plan.
Which is more effective for weight loss - Wegovy vs Orlistat in the UK?
Clinical studies show Wegovy delivers significantly greater weight loss than Orlistat, with patients losing an average of 15% body weight on Wegovy compared to 5-10% with Orlistat. Cured Pharmacy can help you determine which medication suits your weight loss goals and medical history through our online consultation.
Does the NHS cover Wegovy or Orlistat prescriptions?
The NHS may prescribe both Wegovy and Orlistat under strict eligibility criteria, but waiting lists are often long. Cured Pharmacy offers private prescriptions for both medications with fast approval from UK-registered prescribers, allowing you to start treatment without NHS delays.
How do side effects compare between Wegovy and Orlistat?
Orlistat commonly causes digestive side effects like oily stools and urgency, while Wegovy may cause nausea and reduced appetite. At Cured Pharmacy, our prescribers discuss both medication profiles during consultation to help you choose the option with side effects you can best manage for successful weight loss.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.